TY - JOUR
T1 - Prevalence and risk factors of significant persistent pain symptoms after critical care illness
T2 - a prospective multicentric study
AU - the ALGO-RÉA study group
AU - the Atlanréa Group
AU - the Société Française d’Anesthésie-Réanimation–SFAR Research Network
AU - Bourdiol, Alexandre
AU - Legros, Vincent
AU - Vardon-Bounes, Fanny
AU - Rimmele, Thomas
AU - Abraham, Paul
AU - Hoffmann, Clément
AU - Dahyot-Fizelier, Claire
AU - Jonas, Maud
AU - Bouju, Pierre
AU - Cirenei, Cédric
AU - Launey, Yoann
AU - Le Gac, Gregoire
AU - Boubeche, Samia
AU - Lamarche, Edouard
AU - Huet, Olivier
AU - Bezu, Lucillia
AU - Darrieussecq, Julie
AU - Szczot, Magdalena
AU - Delbove, Agathe
AU - Schmitt, Johan
AU - Lasocki, Sigismond
AU - Auchabie, Johann
AU - Petit, Ludivine
AU - Kuhn-Bougouin, Emmanuelle
AU - Asehnoune, Karim
AU - Ingles, Hugo
AU - Roquilly, Antoine
AU - Cinotti, Raphaël
AU - Yavchitz, Amélie
AU - Sigault, Stéphanie
AU - Mazereaud, Aurélien
AU - Bezu, Lucilia
AU - Léger, Maxime
AU - Evain, Jean Noël
N1 - Publisher Copyright:
© 2023, The Author(s).
PY - 2023/12/1
Y1 - 2023/12/1
N2 - Background: Prevalence, risk factors and medical management of persistent pain symptoms after critical care illness have not been thoroughly investigated. Methods: We performed a prospective multicentric study in patients with an intensive care unit (ICU) length of stay ≥ 48 h. The primary outcome was the prevalence of significant persistent pain, defined as a numeric rating scale (NRS) ≥ 3, 3 months after admission. Secondary outcomes were the prevalence of symptoms compatible with neuropathic pain (ID-pain score > 3) and the risk factors of persistent pain. Results: Eight hundred fourteen patients were included over a 10-month period in 26 centers. Patients had a mean age of 57 (± 17) years with a SAPS 2 score of 32 (± 16) (mean ± SD). The median ICU length of stay was 6 [4–12] days (median [interquartile]). At 3 months, the median intensity of pain symptoms was 2 [1–5] in the entire population, and 388 (47.7%) patients had significant pain. In this group, 34 (8.7%) patients had symptoms compatible with neuropathic pain. Female (Odds Ratio 1.5 95% CI [1.1–2.1]), prior use of anti-depressive agents (OR 2.2 95% CI [1.3–4]), prone positioning (OR 3 95% CI [1.4–6.4]) and the presence of pain symptoms on ICU discharge (NRS ≥ 3) (OR 2.4 95% CI [1.7–3.4]) were risk factors of persistent pain. Compared with sepsis, patients admitted for trauma (non neuro) (OR 3.5 95% CI [2.1–6]) were particularly at risk of persistent pain. Only 35 (11.3%) patients had specialist pain management by 3 months. Conclusions: Persistent pain symptoms were frequent in critical illness survivors and specialized management remained infrequent. Innovative approaches must be developed in the ICU to minimize the consequences of pain. Trial registration. NCT04817696. Registered March 26, 2021.
AB - Background: Prevalence, risk factors and medical management of persistent pain symptoms after critical care illness have not been thoroughly investigated. Methods: We performed a prospective multicentric study in patients with an intensive care unit (ICU) length of stay ≥ 48 h. The primary outcome was the prevalence of significant persistent pain, defined as a numeric rating scale (NRS) ≥ 3, 3 months after admission. Secondary outcomes were the prevalence of symptoms compatible with neuropathic pain (ID-pain score > 3) and the risk factors of persistent pain. Results: Eight hundred fourteen patients were included over a 10-month period in 26 centers. Patients had a mean age of 57 (± 17) years with a SAPS 2 score of 32 (± 16) (mean ± SD). The median ICU length of stay was 6 [4–12] days (median [interquartile]). At 3 months, the median intensity of pain symptoms was 2 [1–5] in the entire population, and 388 (47.7%) patients had significant pain. In this group, 34 (8.7%) patients had symptoms compatible with neuropathic pain. Female (Odds Ratio 1.5 95% CI [1.1–2.1]), prior use of anti-depressive agents (OR 2.2 95% CI [1.3–4]), prone positioning (OR 3 95% CI [1.4–6.4]) and the presence of pain symptoms on ICU discharge (NRS ≥ 3) (OR 2.4 95% CI [1.7–3.4]) were risk factors of persistent pain. Compared with sepsis, patients admitted for trauma (non neuro) (OR 3.5 95% CI [2.1–6]) were particularly at risk of persistent pain. Only 35 (11.3%) patients had specialist pain management by 3 months. Conclusions: Persistent pain symptoms were frequent in critical illness survivors and specialized management remained infrequent. Innovative approaches must be developed in the ICU to minimize the consequences of pain. Trial registration. NCT04817696. Registered March 26, 2021.
KW - Critical care
KW - ID-pain
KW - Neuropathic pain
KW - Pain
KW - Post-intensive care syndrome
UR - http://www.scopus.com/inward/record.url?scp=85160144113&partnerID=8YFLogxK
U2 - 10.1186/s13054-023-04491-w
DO - 10.1186/s13054-023-04491-w
M3 - Article
C2 - 37226261
AN - SCOPUS:85160144113
SN - 1364-8535
VL - 27
JO - Critical Care
JF - Critical Care
IS - 1
M1 - 199
ER -